Boryung Pharm’s ‘Kanarb Tab’ recording highest manufacturing performance last year among Korean new drugs
Among pharmaceutical products approved as new drug developed in Korea, a product which recorded the highest sales was ‘Kanarb Tab,’ a Boryung Pharm’s antihypertensive.
In addition, among the 26 new drugs developed in Korea, there were only 5 products with a manufacturing performance more than KR...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
